MedTrace Logo

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

NCT01598805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2012-11-16

No results posted yet for this study

Summary

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

Conditions

  • Venous Thromboembolism

Interventions

BEHAVIORAL

electronic alerts

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Juerg Blaser, Prof. PhD · University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598805 on ClinicalTrials.gov